Skip to main content
. 2019 Aug 2;12(10):1386–1394. doi: 10.1016/j.tranon.2019.07.013

Figure 2.

Figure 2

Gene mutations, amplifications, and homozygous deletions in patients treated with combination therapy of eribulin and olaparib.